Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1726 to 1740 of 9022 results

  1. MT633 FreeO2 Automatic Oxygen Titration

    Topic prioritisation

  2. MT658 Quit Genius for Smoking Cessation

    Topic prioritisation

  3. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

    Topic prioritisation

  4. Accuro handheld ultrasound device for locating intervertebral space for administration of spinal anaesthesia

    Topic prioritisation

  5. NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds

    Topic prioritisation

  6. MTEP - Routing Butterfly IQ ultrasound scanner MT635 (MIB254)

    Topic prioritisation

  7. PROPEL (mometasone furoate implant, 370ug) MT578 (MIB253)

    Topic prioritisation

  8. Woundexpress MT602 (MIB261)

    Topic prioritisation

  9. Acumen IQ sensor MT616 (MIB266)

    Topic prioritisation

  10. ABP-654 (ustekinumab biosimilar) for previously treated moderate to severe plaque psoriasis [TSID11790]

    Topic prioritisation

  11. Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]

    Topic prioritisation

  12. Tolebrutinib for treating primary progressive multiple sclerosis [TSID12166]

    Topic prioritisation

  13. Tarlatamab for treating extensive stage small-cell lung cancer that has progressed after platinum-based chemotherapy [ID6617]

    In development Reference number: GID-TA11812 Expected publication date:  13 January 2027

  14. Apadamtase alfa for treating congenital thrombotic thrombocytopenic purpura caused by ADAMTS-13 deficiency [ID6192]

    In development Reference number: GID-TA11130 Expected publication date: TBC

  15. Tucatinib with pertuzumab and trastuzumab for maintenance treatment of HER2-positive unresectable advanced breast cancer after induction chemotherapy [ID6402]

    Awaiting development Reference number: GID-TA11487 Expected publication date:  27 May 2027